Katherine Dacey

Goodwin

Contact
View Bio
RSS

Latest Posts › Pharmaceutical Industry

Share:

2022 Year in Review: Securities Litigation Against Life Sciences Companies

We are proud to present our seventh annual Securities Litigation Year in Review publication, in which we analyze data for securities class actions filed nationally against publicly traded pharmaceutical, biotechnology,...more

3/6/2023  /  Appellate Courts , Biotechnology , Class Action , Corporate Counsel , Life Sciences , Pharmaceutical Industry , Securities , Securities and Exchange Commission (SEC) , Securities Litigation , Securities Regulation

2021 Year in Review: Securities Litigation Against Life Sciences Companies

Summary of 2021 Trends, Themes, and Takeaways - We are proud to present our sixth annual Securities Litigation Year in Review publication, in which we analyze data for securities class actions filed nationally against...more

2/17/2022  /  Biotechnology , Class Action , Life Sciences , Pharmaceutical Industry , Securities Litigation , Securities Transactions , Securities Violations , Special Purpose Acquisition Companies (SPACs)
2 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide